Corrected cholesterol, a novel marker for predicting semen post-thaw quality: a pilot study

Abstract

Semen cryopreservation is the recommended method for protecting the fertility of men before they undergo iatrogenic treatments. However, post-thaw sperm quality is highly variable between and within individuals. Thus, prediction of post-thaw quality has not been achieved with great certainty. Men (n = 101) attending our andrology clinic each produced a single ejaculate for semen analysis and semen cryopreservation. Post-thaw semen quality was examined for associations with traditional and novel semen and seminal plasma parameters. This current research demonstrates that the cholesterol concentration of human sperm is associated with ejaculate tolerance to cryopreservation. Corrected cholesterol, calculated as the difference between the cholesterol of semen and the cholesterol of cell free seminal plasma, is predictive of post-thaw motility. This may have potential as a method to guide the number of ejaculates stored for individual patients before iatrogenic treatment and/or for the appropriate selection of ART with frozen/thawed semen.

Keywords:

• Semen analysis
• cryopreservation
• sperm banking

Acknowledgements

We are grateful to Andrology Laboratory and Clinical Chemistry laboratories of Hammersmith Hospital, Imperial College NHS Trust, London, United Kingdom, W12 0HS. Both laboratories donated all the consumables and reagents used in the study.

Disclosure statement

For this study, we no received no funding or financial support other than the donation of reagents and consumables used. The authors declare that there is no conflict of interests. The authors alone are responsible for the content and writing of the paper.